Aspira Women's Health Inc.

6.29+0.3000+5.01%Vol 188.01K1Y Perf 483.18%
Apr 13th, 2021 15:43 DELAYED
BID6.27 ASK6.30
Open6.02 Previous Close5.99
Pre-Market6.02 After-Market-
 0.03 0.50%  - -
Target Price
12.00 
Analyst Rating
— — 0.00
Potential %
92.93 
Finscreener Ranking
★★★     50.83
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     45.74
Insiders Value % 3/6/12 mo.
-/-/97 
Growth Ranking
★★★     52.47
Insiders Shares Cnt. % 3/6/12 mo.
-/-/96 
Income Ranking
★★★★ —    -
Market Cap702.70M 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
55.82 
Earnings Date
13th May 2021

Today's Price Range

6.026.29

52W Range

0.920010.54

5 Year PE Ratio Range

-3.30-4.70

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-4.92%
1 Month
-21.80%
3 Months
-2.44%
6 Months
82.62%
1 Year
483.18%
3 Years
-87.84%
5 Years
-83.02%
10 Years
-69.12%

TickerPriceChg.Chg.%
AWH6.290.30005.01
AAPL134.543.30002.51
GOOG2 270.9816.19000.72
MSFT258.372.46000.96
XOM55.680.18000.32
WFC39.82-0.9500-2.33
JNJ159.52-2.1200-1.31
FB310.10-1.4400-0.46
GE13.46-0.1300-0.96
JPM154.24-1.7100-1.10
Financial StrengthValueIndustryS&P 500US Markets
2.70
2.90
0.26
0.53
5.60
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
26.60
-386.60
-380.90
-406.30
5.93
RevenueValueIndustryS&P 500US Markets
3.43M
0.03
18.15
20.56
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.04-0.58-1 350.00
Q03 2020-0.04-0.040.00
Q02 2020--0.04-
Q01 2020--0.04-
Q04 2019--0.03-
Q03 2019--0.04-
Q02 2019--0.06-
Q01 2019--0.05-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.23-475.00Negative
6/2021 QR-0.21-425.00Negative
12/2021 FY-0.68-277.78Negative
12/2022 FY-0.89-394.44Negative
Next Report Date13th May 2021
Estimated EPS Next Report-0.23
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume188.01K
Shares Outstanding111.72M
Trades Count1.99K
Dollar Volume3.31M
Avg. Volume855.55K
Avg. Weekly Volume479.51K
Avg. Monthly Volume901.12K
Avg. Quarterly Volume893.02K

Aspira Women's Health Inc. (NYSE: AWH) stock closed at 5.99 per share at the end of the most recent trading day (a -3.85% change compared to the prior day closing price) with a volume of 509.33K shares and market capitalization of 702.70M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 53 people. Aspira Women's Health Inc. CEO is Valerie Palmieri.

The one-year performance of Aspira Women's Health Inc. stock is 483.18%, while year-to-date (YTD) performance is -10.73%. AWH stock has a five-year performance of -83.02%. Its 52-week range is between 0.92 and 10.54, which gives AWH stock a 52-week price range ratio of 55.82%

Aspira Women's Health Inc. currently has a PE ratio of -35.00, a price-to-book (PB) ratio of 72.42, a price-to-sale (PS) ratio of 195.20, a price to cashflow ratio of 18.60, a PEG ratio of 2.32, a ROA of -103.32%, a ROC of -100.40% and a ROE of -186.20%. The company’s profit margin is 5.93%, its EBITDA margin is -380.90%, and its revenue ttm is $3.43 Million , which makes it $0.03 revenue per share.

Of the last four earnings reports from Aspira Women's Health Inc., there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.23 for the next earnings report. Aspira Women's Health Inc.’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for Aspira Women's Health Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Aspira Women's Health Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aspira Women's Health Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of 36.00%.

Aspira Women's Health Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.85, ATR14 : 0.77, CCI20 : -109.42, Chaikin Money Flow : -0.30, MACD : -0.26, Money Flow Index : 39.28, ROC : -9.24, RSI : 45.75, STOCH (14,3) : 2.97, STOCH RSI : 0.63, UO : 30.06, Williams %R : -97.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aspira Women's Health Inc. in the last 12-months were: David R. Schreiber (Sold 50 000 shares of value $139 000 ), Jack W Schuler (Buy at a value of $8 000 002), Jack W Schuler (Option Excercise at a value of $1 315 008), James S. Burns (Sold 0 shares of value $-40 500 ), James T. LaFrance (Option Excercise at a value of $36 832), Valerie Palmieri (Sold 0 shares of value $-13 556 ), Veronica G.H. Jordan (Sold 0 shares of value $-18 076 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
5 (100.00 %)
5 (100.00 %)
6 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary Rating---

Aspira Women's Health Inc.

Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiX testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.

CEO: Valerie Palmieri

Telephone: +1 512 519-0400

Address: 12117 Bee Caves Road, Building Three, Austin 78738, TX, US

Number of employees: 53

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

66%34%

Bearish Bullish

54%46%

News

Stocktwits